ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
71.225
0.39%
US Dollar vs AUD
1.45141
0.04%
Bitcoin
65,346.84
0.25%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Portage Biotech Inc (PRTG)

  7. Portage Biotech Inc (PRTG) News

PRTG

Portage Biotech (PRTG)

Portage Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTG
DateTimeSourceHeadlineSymbolCompany
23/09/202423:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRTGPortage Biotech Inc
21/09/202401:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PRTGPortage Biotech Inc
28/08/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTGPortage Biotech Inc
27/08/202422:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
27/08/202422:00GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business UpdateNASDAQ:PRTGPortage Biotech Inc
27/08/202420:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
27/08/202420:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
15/08/202422:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
15/08/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
15/08/202421:00GlobeNewswire Inc.Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business UpdateNASDAQ:PRTGPortage Biotech Inc
15/08/202407:29Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRTGPortage Biotech Inc
13/08/202422:52Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
13/08/202422:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
13/08/202421:00GlobeNewswire Inc.Portage Biotech Announces 1-for-20 Reverse Stock SplitNASDAQ:PRTGPortage Biotech Inc
02/08/202406:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
12/04/202422:01GlobeNewswire Inc.Portage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesNASDAQ:PRTGPortage Biotech Inc
26/03/202423:01GlobeNewswire Inc.Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesNASDAQ:PRTGPortage Biotech Inc
09/03/202409:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
09/03/202409:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
29/02/202409:19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
29/02/202409:10GlobeNewswire Inc.Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateNASDAQ:PRTGPortage Biotech Inc
15/02/202407:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRTGPortage Biotech Inc
19/01/202409:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
05/01/202400:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
05/01/202400:00GlobeNewswire Inc.Portage Biotech Reports Business and Strategic UpdateNASDAQ:PRTGPortage Biotech Inc
02/12/202308:05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRTGPortage Biotech Inc
29/11/202308:03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
29/11/202308:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
29/11/202308:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
14/11/202322:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRTGPortage Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:PRTG

Your Recent History

NYSE
DOCN
DigitalOcean
TG
04I
InVivo Therapeutics
BIT
P21UL4
NLBNPIT21UL4 20991231 66...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved